# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001295947-20-000032
Filing Date
2020-11-05
Accepted
2020-11-05 06:07:55
Documents
39
Period of Report
2020-11-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | pbh-20201105.htm iXBRL | 8-K | 44218
2 | EX-99.1 | exhibit991fy21-q2earni.htm | EX-99.1 | 458543
3 | EX-99.2 | exhibit992pbhinvestorsec.htm | EX-99.2 | 37424
9 | GRAPHIC | exhibit992pbhinvestorsec001.jpg | GRAPHIC | 134389
10 | GRAPHIC | exhibit992pbhinvestorsec002.jpg | GRAPHIC | 196944
11 | GRAPHIC | exhibit992pbhinvestorsec003.jpg | GRAPHIC | 48856
12 | GRAPHIC | exhibit992pbhinvestorsec004.jpg | GRAPHIC | 45697
13 | GRAPHIC | exhibit992pbhinvestorsec005.jpg | GRAPHIC | 110794
14 | GRAPHIC | exhibit992pbhinvestorsec006.jpg | GRAPHIC | 46051
15 | GRAPHIC | exhibit992pbhinvestorsec007.jpg | GRAPHIC | 96793
16 | GRAPHIC | exhibit992pbhinvestorsec008.jpg | GRAPHIC | 125685
17 | GRAPHIC | exhibit992pbhinvestorsec009.jpg | GRAPHIC | 94389
18 | GRAPHIC | exhibit992pbhinvestorsec010.jpg | GRAPHIC | 45932
19 | GRAPHIC | exhibit992pbhinvestorsec011.jpg | GRAPHIC | 84313
20 | GRAPHIC | exhibit992pbhinvestorsec012.jpg | GRAPHIC | 95247
21 | GRAPHIC | exhibit992pbhinvestorsec013.jpg | GRAPHIC | 115217
22 | GRAPHIC | exhibit992pbhinvestorsec014.jpg | GRAPHIC | 124396
23 | GRAPHIC | exhibit992pbhinvestorsec015.jpg | GRAPHIC | 43359
24 | GRAPHIC | exhibit992pbhinvestorsec016.jpg | GRAPHIC | 104549
25 | GRAPHIC | exhibit992pbhinvestorsec017.jpg | GRAPHIC | 37684
26 | GRAPHIC | exhibit992pbhinvestorsec018.jpg | GRAPHIC | 140704
27 | GRAPHIC | exhibit992pbhinvestorsec019.jpg | GRAPHIC | 105292
28 | GRAPHIC | exhibit992pbhinvestorsec020.jpg | GRAPHIC | 103236
29 | GRAPHIC | exhibit992pbhinvestorsec021.jpg | GRAPHIC | 108603
30 | GRAPHIC | exhibit992pbhinvestorsec022.jpg | GRAPHIC | 109302
31 | GRAPHIC | exhibit992pbhinvestorsec023.jpg | GRAPHIC | 79237
| Complete submission text file | 0001295947-20-000032.txt |  | 3749210

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
4 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | pbh-20201105.xsd | EX-101.SCH | 2445
5 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | pbh-20201105_cal.xml | EX-101.CAL | 727
6 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | pbh-20201105_def.xml | EX-101.DEF | 1660
7 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | pbh-20201105_lab.xml | EX-101.LAB | 24270
8 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | pbh-20201105_pre.xml | EX-101.PRE | 12663
32 | EXTRACTED XBRL INSTANCE DOCUMENT | pbh-20201105_htm.xml | XML | 10589

Mailing Address 660 WHITE PLAINS RD. TARRYTOWN NY 10591
Business Address 660 WHITE PLAINS RD. TARRYTOWN NY 10591 (914) 524-6800
Prestige Consumer Healthcare Inc. (Filer) CIK: 0001295947 (see all company filings)

EIN.: 201297589 | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-32433 | Film No.: 201288482
SIC: 2834 Pharmaceutical Preparations